FDA Approves GW Pharma’s Cannabis-Derived Epidiolex to Treat Epilepsy

New Cannabis Ventures
By NCV NewswireJun 25, 2018, 1:00 pm21 pts
FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy June 25, 2018 The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

We Need To Debunk Marijuana Rescheduling Myths As Trump Weighs Action (Op-Ed) 76

Using Cannabis Seeds During The Beer Brewing Process ‘Enhances The Nutritional Value,’ Study Shows 75

From ‘sin taxes’ to potency pricing: Modern approaches to excise tax policy 72

Federal Agent Warns DC Residents Trump Is ‘Tired Of’ Public Marijuana Consumption Amid ‘Surge’ To Combat Crime In Nation’s Capitol 70

TerrAscend Renews, Replenishes $10M Share Repurchase Program 69

FLUENT Partners With Connected Cannabis at its New Cultivation Facility in New York 68

Goldflower Cannabis Opening 10th Florida Medical Dispensary in Lakeland 58

Study: Most Chronic Musculoskeletal Pain Cannabis Patients Stop Treatment Within One Year 13

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.